The ABC Transporter/Channel Superfamily
The ATP-binding cassette (ABC) superfamily is probably the largest and most diverse family of proteins that mediate the selective movement of solutes across biological membranes. Many ABC proteins are of considerable clinical significance: human P-glycoprotein (P-gp) confers resistance of cancers to chemotherapeutic drugs, Pghl has a role in chloroquine resistance of the malarial parasite, SUR is the receptor for sulphonylureas used to treat diabetes and is mutated in patients with persistent hyperinsulinemic hypoglycemia of infancy, and genes encoding ABC transporters are mutated in inherited syndromes such as adrenoleukodystrophy, Zellweger syndrome, and cystic fibrosis. Thus, the molecular mechanisms by which ABC transporters operate, and their physiological roles, are of more than passing academic interest.
Over 100 ABC transporters have been identified in species ranging from Escherichia coil to human (Higgins, 1992) . Each is specific for a single substrate or group of related substrates that can range from inorganic ions to sugars and amino acids, complex polysaccharides and proteins. All ABC transporters share a common domain organization with four "core" domains that may be expressed as separate polypeptides or can be fused together into larger, multidomain proteins ( Figure 1 ). Two transmembrane domains span the membrane multiple times to form the pathway through which solute crosses the membrane and determine the substrate specificity/selectivity of the transporter. Two ATP-binding domains, Iocated at the cytosolic face of the membrane, couple ATP hydrolysis to solute movement. These latter domains share 30%-40% sequence identity with the equivalent domains from other ABC transporters, irrespective of their substrate specificity or species of origin, readily distinguishing these ATP-binding cassettes from other nucleotidebinding proteins.
Despite many elegant genetic and biochemical studies, we are still some way from understanding the molecular mechanisms by which ABC transporters mediate transmembrane translocation of solute. This is, principally, because of a lack of structural information. The vast majority of ABC proteins are active transporters, utilizing the energy of ATP hydrolysis to pump solute across the membrane. However, the finding that one apparently typical ABC transporter, the cystic fibrosis gene product CFTR (for cystic fibrosis transmembrane conductance regulator), is an ion channel has challenged conventional views on the distinction between channels and transporters. It is not known whether any other ABC proteins are channels rather than transporters. However, over the past year, it has emerged that several ABC proteins regulate heterologous channels, and perhaps other membrane proteins, besides possessing their own intrinsic transporter/channel activities.
ABC Transporters as Channel Regulators
The Multidrug Resistance P.gp
The human multidrug resistance P-gp is an active transporter that utilizes the energy of ATP hydrolysis to pump hydrophobic compounds (including chemotherapeutic drugs) out of cells. Expression of P-gp in several cell types also increases the magnitude of cell swelling-activated CIcurrents Gill et al., 1992) . Although the simplest interpretation of the initial data was that P-gp The four core domains are colored, the transmembrane domains in blue and the ATP-binding domains in yellow. In some transporters, the four core domains are expressed as separate polypeptides (e.g., the oligopeptide permease of S. typhimurium). In others, the domains can be fused in a variety of configurations. For example, the two ATPbinding domains are fused into a single polypeptide in the ribose transporter of E. coil, and the two transmembrane domains are fused in the Fe-hydroxamate transporter of E. coll. The mammalian TAP1-TAP2 peptide transporter, associated with major histocompatibility complex (MHC) class I antigen presentation, is a complex of two polypeptides, each comprising a transmembrane domain fused to an ATPbinding domain. The human multidrug resistance P-gp and the cystic fibrosis gene product CFTR have all four domains fused into a single multidomain polypeptide. In some transporters, one polypeptide is present as a homodimer in the transport complex to provide the full complement of four domains (e.g., HisP in the histidine permease of S. typhimurium). Certain ABC transporters include "extra" domains (illustrated in white), such as the periplasmic binding proteins of bacterial uptake systems or the regulatory R domain of CFTR, which provide specific, additional functions required by individual transporters. For references and further details, see Higgins (1992) . might itself possess intrinsic channel activity, subsequent studies have shown that P-gp is not a channel but that it regulates an endogenous channel protein (Luckie et al., 1994; Hardy et al., 1995) . P-gp alters the sensitivity of channel activation to osmotic gradients and can impose protein kinase C dependency on channel activation. The identity of the swelling-activated channel protein is not known, although it appears to have a central role in cell volume control. Expression of the related ABC protein MRP, which also confers drug resistance on cells, also alters CI-and K ÷ currents in some cell types (Jirsch et al., 1993) .
CFTR
The cystic fibrosis gene product CFTR, besides being a CI-channel itself, regulates the activity of several other ion channels, and this regulation may be important in the pathophysiology of cystic fibrosis. First, an outwardly rectifying CI-channel (ORCC) is abnormally regulated in cystic fibrosis cells. It was once suspected that the ORCC might be encoded by the cystic fibrosis gene, although it is now clear that the ORCC and CFTR are distinct channel proteins. Expression of CFTR imposes protein kinase A regulation on the ORCC, and this regulation can be mimicked in reconstituted systems (Egan et al., 1993; Gabriel et al., 1993; Schwiebert et al., 1995; Jovov et al., 1995) . Second, it has long been known that Na + absorption is increased in the airways of cystic fibrosis patients. This cannot be a simple indirect electrochemical response to altered CIsecretion; instead, the activity of the Na ÷ channel (ENaC) itself appears to be altered (Chinet et al., 1994) . Third, a Ca2+-activated CI-channel is up-regulated in many cystic fibrosis cells (Grubb et al., 1994) . Transfection of cystic fibrosis cells with CFTR restores to normal the activities of both this Ca2+-activated CI-channel and the Na + channel (Johnson et al., 1995 , Stutts et al., 1995 .
Malarial pfmdrl
The Pghl protein of Plasmodium falciparum, encoded by the pfmdrl gene, contributes to antimalarial drug resistance. Pghl facilitates accumulation of chloroquine in the digestive vacuole: pfmdrl mutants show reduced accumulation and, hence, chloroquine resistance. Although analogy with human P-gp would suggest that Pghl is a chloroquine transporter, chloroquine resistance is a complex phenotype, pfmdrl mutations increase vacuolar pH, and expression of wild-type (but not mutant) Pghl in CHO cells acidifies the lysosomes (van Es et al., 1994) . These changes in pH may contribute to reduced accumulation of weak bases such as chloroquine and hence to drug resistance. Intriguingly, human P-gp also acidifies the cytoplasm, and this might contribute to the reduced accumulation of some drugs (Roepe et al., 1994) . There is no evidence that Pghl and P-gp are proton pumps, and their effects on pH seem to be independent of drug accumulation. It seems plausible that Pghl (and possibly also P-gp) alter [H+]ATPase activity (van Es et al., 1994) .
Bacterial Systems
As is often the case, the power of bacterial genetics has provided the cleanest demonstration that an ARC transporter also acts as a channel regulator. The sapABCDF genes of Salmonella typhimurium encode an ABC transporter that confers resistance to toxic peptides produced by epithelial cells (e.g., defensins), probably by transporting them into the cytoplasm where they are degraded or detoxified (Parra-Lopez et al., 1993) . Two additional gene products are also required for resistance to these toxic peptides, SapG and SapJ. Unexpectedly, the sapABCDF, sapG, and sapJ loci were found to be true homologs of the trkE, trkA, and trkH loci of E. coil, respectively, which are required for Trk K ÷ channel activity (Parra-Lopez et al., 1994) . TrkH (SapJ) is a membrane-spanning protein believed to form the K ÷ channel pore, while the cytoplasmic NADH-binding protein TrkA (SapG) and the TrkE (SapABCDF) ABC transporter are regulators of this channel. The peptide transporter and K ÷ channel activities are independent and separable processes (Aspedon et al., 1995, Am. Soc. Microbiol., abstract) . The ami locus of Streptococcus may also encode an ABC transporter that modulates ion transport activities, ami mutations were originally isolated by their abilty to confer resistance to aminopterins, methotrexate, and other cytotoxics, yet the ami locus encodes an ABC transporter that does not appear to transport these compounds but is specific for peptides (AIIoing et al., 1990) . Instead, ami mutants exhibit altered membrane potential that, indirectly, leads to decreased methotrexate and aminopterin sensitivity (Trombe, 1993) .
The Sulphonylurea Receptor SUR
Another intriguing example of considerable clinical significance is emerging from studies of the ATP-sensitive K ÷ channel (KATP). Blockade of this channel with sulphonylureas in pancreatic 13 cells modulates insulin release. In an effort to clone the gene encoding KATP, the gene encoding the sulphonylurea-binding protein (SUR) has recently been isolated . Mutations in this gene are associated with persistent hyperinsulinemic hypoglycemia of infancy (Thomas et al., 1995) . However, SUR is an ABC transporter and does not appear to be the channel itself. Instead, it seems probable ~that SUR imposes sulphonylurea sensitivity on another protein that forms the channel. The precise identity of the channel protein is not yet known. Although a candidate, I~Tp, has been proposed (Ashford et al., 1994) , IKATP (also called cardiac inward rectifier [CIR] ) forms a heteromultimer with the GIRK1 channel to generate the G protein-gated atrial K ÷ channel IKAch, complicating any analysis (Krapivinsky et al., 1995) .
Mechanisms of Regulation
How do ABC transporters regulate the activity of heterologous channels? Is there a single mechanism, or do different ABC transporters act by different mechanisms? Although we have few answers, a number of clues are emerging.
The possibility that regulation is at the level of gene expression, rather than channel activity, can be excluded for several of the systems described here. For example, CFTR alters Na + channel activity but does not alter the amount of Na ÷ channel expressed in the cell (Stutts et al., 1995) ; the ORCC is present in membranes of non-CFTRexpressing cells but can only be activated normally when CFTR is present (Egan et al., 1993; Gabriel et al., 1993) ; P-gp regulates the threshold osmolarity at which cell swelling-regulated CI-channels are activated, rather than the maximum magnitude of channel activity (Luckie et al., 1994; Hardy et al., 1995) .
The most straightforward mechanism by which an ABC transporter might regulate a heterologous channel is by transporting a regulatory molecule (Figure 2A ): in this model, regulation is a secondary consequence of the normal transporter/channel activity of the ABC protein and does not require that the protein is truly bifunctional. Although some ABC transporters doubtless transport regulatory molecules, most, if not all, of the effects described here are not mediated by this mechanism. For example, a mutation in the ATP-binding domain of the multidrug resistance P-gp transporter reduces transport activity to an undetectable level yet does not prevent P-gp acting as a channel regulator . A recent intriguing report shows that CFTR increases ATP efflux from cells and that this ATP interacts with extracellular receptors to activate the ORCC (Schwiebert et al., 1995) . This, potentially, provides insight into a mechanism of heterologous channel regulation. It remains to be tested whether ATP release is mediated via the intrinsic CI-channel activity of CFTR itself or via a heterologous pathway that is activated by CFTR, independently of its CI-channel activity. If, then, we assume that the regulation of heterologous proteins by ABC transporters is distinct from their intrinsic channel/transporter activity, many direct and indirect mechanisms can be envisaged (Figure 2 ). These are not mutually exclusive, and many variations can be entertained. However, they all require that the ABC transporters are truly bifunctional, with a regulatory activity distinct from and additional to any intrinsic transporter/channel activity.
Among the indirect mechanisms is vesicle trafficking (Figure 2B) , in which the ABC protein facilitates insertion of additional channel proteins into the membrane. CFTR has been reported to influence vesicle trafficking in some cells (Bradbury et al., 1992) , and this may be important in specific circumstances. However, membrane insertion cannot account for all of the regulatory effects described here: CFTR regulates ORCC activity in isolated membrane patches where trafficking cannot apply, and, of course, membrane trafficking does not occur in prokaryotic cells. Another indirect mechanism, although perhaps unlikely, is through altered membrane lipid composition or organization. Many transporters and channels are sensitive to the nature of membrane lipids, and at least one ABC transporter, the MDR2 gene product, is known to transport phospholipids (Reutz and Gros, 1994) . Such a mechanism would, however, lack specificity.
Direct protein-protein interactions seem, at least to this author, the most likely mechanism by which ABC transporters might regulate heterologous proteins. There is little direct evidence either for or against this hypothesis, although a recent study provides an indication that CFTR may regulate ENaC (the Na--channel) via protein-protein interactions (Stutts et al., 1995) . Most simply, the ABC protein would form a complex with heterologous channel proteins in the membrane ( Figure 2C ). This could generate specificity of regulation and is realistic for both prokaryotic and eukaryotic systems. Alternatively, interactions might involve intermediate proteins, such as cytoskeletal components ( Figure 2D ). There is a precedent in the erythrocyte membrane for cross-talk between membrane proteins via the cytoskeleton: the band 3 anion exchanger Na÷/ K÷-ATPase and the glucose transporter influence each other's activities through interactions with ankyrin and spectrin (Mills et al., 1994) .
Physiological and Clinical Significance
The effects of ABC transporters on the activity of heterologous channels and other proteins have generally been observed in perturbed systems, either after heterologous overexpression or in mutants and transgenic mouse models. It can, therefore, reasonably be asked: do these regulatory effects reflect functional interactions that occur in normal cells, or are they a fortuitous consequence of experimental perturbations? Although there is little direct evidence that these regulatory phenomena are relevant to normal cells, a compelling case is provided by the increasing body of indirect evidence. Furthermore, even if these regulatory interactions are not relevant in normal cells, there is no doubt that several are of real significance in diseased states (e.g., cystic fibrosis and multidrug resistance) and so deserve serious attention.
Why do such regulatory interactions occur? If regulation by ABC transporters is of real physiological relevance, the transporter must impose novel responses on the channel. This is seen for P-gp and CFTR, which appear to impose regulation by protein kinases on associated channels. Some ABC transporters may confer regulation by small molecules. For example, SU R is believed to confer sulphonylurea sensitivity on the KATP channel, possibly mimicking an endogenous regulatory sulphonylurea. Cytotoxic drugs can also modify the ability of P-gp to modulate cell swelling-activated CI-channels , possibly reflecting regulation by an unknown endogenous molecule. As ABC transporters span the cell membrane, extracellular regulatory molecules may also be sensed. A precedent for transmembrane signal transduction by an ABC transporter is provided by the PstSCAB phosphate transporter of E. coll. Together with the cytoplasmic PhoU protein, PstSCAB is required for the repression of many E. coil genes by extracellular phosphate (Steed and Wanner, 1993) . Phosphate transport is not necessary for this repression, implying that the ABC transporter transduces a signal across the membrane to modulate PhoU activity and, hence, gene expression. The interaction of the maltose-binding protein with the E. coil maltose ABC transporter at the extracellular face of the membrane also initiates a signal, presumed to be a conformational change, that is transmitted across the membrane to the ATPbinding domains (Davidson et al., 1992) . Intriguingly, the ATP-binding domains of ABC transporters resemble Ras and other G proteins, and a conformational change in these domains could have regulatory consequences for proteins with which they interact. Although, in these bacterial examples, channel regulation is not involved, this transduction mechanism could equally be applied to a channel or any other interacting protein.
Concluding Comments
There is rapidly emerging evidence that a number of ABC transporters are bifunctional, regulating channel activity independently of their normal transporter/channel activity. In some cases, ABC transporters may regulate membrane-associated proteins other than channels. It is not known what proportion of ABC transporters have these regulatory functions. These regulatory events have considerable physiological consequences, at least in certain disease states. Furthermore, the finding that channel activities can be modulated by other membrane proteins, perhaps by direct interactions, may account for the difficulties in isolating some channels and their genes. Elucidating the mechanisms of these regulatory phenomena is essential if we are to integrate the functions of individual ABC transporters and channels into cell physiology and to understand the complex system that is the cell membrane.
